|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.26 SEK | +2.47% |
|
-1.30% | -19.20% |
| 20/07 | SynAct Pharma Draws SEK50 Million from New Financing Facility | MT |
| 20/07 | Synact Pharma secures access to financing of up to €9.0m | FW |
| Market Cap | 102.25Cr 11Cr 9.32Cr 8.67Cr 7.96Cr 15Cr 1.02TCr 15Cr 40Cr 509.51Cr 40Cr 39Cr 1.71TCr | P/E 2026 * |
-12.3x | P/E 2027 * | -24x |
|---|---|---|---|---|---|
| Enterprise Value | 100.5Cr 11Cr 9.16Cr 8.53Cr 7.83Cr 15Cr 1.01TCr 15Cr 39Cr 500.8Cr 40Cr 39Cr 1.68TCr | EV / Sales 2026 * |
7.24x | EV / Sales 2027 * | 49.5x |
| Free-Float |
70.28% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: SynAct Pharma AB
| 1 day | +2.47% | ||
| 1 week | -1.30% | ||
| Current month | -13.25% | ||
| 1 month | -13.25% | ||
| 3 months | +3.87% | ||
| 6 months | -12.00% | ||
| Current year | -19.20% |
| 1 week | 17.08 |  | 18.9 |
| 1 month | 17.08 | | 23.5 |
| Current year | 7.05 | | 24.4 |
| 1 year | 7.05 | | 25.3 |
| 3 years | 4.98 | | 124.6 |
| 5 years | 4.98 | | 146 |
| 10 years | 4.8 | | 146 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jeppe Øvlesen
CEO | Chief Executive Officer | 64 | 01/01/2014 |
Ann Kristin Led
DFI | Director of Finance/CFO | - | 01/03/2026 |
Kirsten Harting
CTO | Chief Tech/Sci/R&D Officer | - | 15/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Jeppe Øvlesen
BRD | Director/Board Member | 64 | 20/03/2024 |
Anders Kronborg
CHM | Chairman | 62 | 20/03/2024 |
Sten Scheibye
BRD | Director/Board Member | 74 | 20/03/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06/03/26 | Buy | Chief Operating Officer | 2,750 | 0.0052% | ||
| 31/12/25 | Buy | Chief Technology Officer | 3,529 | 0.0066% | ||
| 22/12/25 | Buy | Chairman | 3,470 | 0.0065% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.47% | -1.30% | -17.00% | -80.02% | 10Cr | |
| -0.53% | -3.12% | +51.15% | +150.58% | 1,03000Cr | |
| +0.21% | -1.13% | +53.26% | +46.92% | 62TCr | |
| -2.51% | -2.33% | +32.56% | +66.35% | 45TCr | |
| +0.06% | +1.17% | +36.21% | +31.25% | 35TCr | |
| -0.14% | -0.83% | +33.24% | +40.28% | 30TCr | |
| -0.69% | -0.44% | +9.86% | +14.23% | 27TCr | |
| -7.37% | -4.31% | -5.69% | -41.99% | 23TCr | |
| -0.64% | +3.68% | +27.80% | +62.95% | 21TCr | |
| -0.82% | -0.50% | +13.46% | +69.41% | 16TCr | |
| Average | -0.74% | +3.47% | +23.48% | +36.00% | 36.13TCr | |
| Weighted average by Cap. | -0.69% | +4.87% | +36.61% | +70.84% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 14Cr 1.45Cr 1.26Cr 1.18Cr 1.08Cr 2.04Cr 138.87Cr 2.07Cr 5.45Cr 69Cr 5.46Cr 5.34Cr 231.83Cr | 2.12Cr 22.18L 19.28L 17.94L 16.47L 31.11L 21Cr 31.59L 83.01L 11Cr 83.28L 81.45L 35Cr |
| Net income | 5.22Cr 54.7L 47.55L 44.26L 40.64L 76.74L 52Cr 77.93L 2.05Cr 26Cr 2.05Cr 2.01Cr 87Cr | -2.6Cr -27.31L -23.74L -22.1L -20.29L -38.31L -26Cr -38.9L -1.02Cr -13Cr -1.03Cr -1Cr -44Cr |
| Net Debt | -1.75Cr -18.33L -15.93L -14.83L -13.62L -25.71L -17Cr -26.11L -68.6L -8.71Cr -68.83L -67.32L -29Cr | 2.49Cr 26.07L 22.66L 21.09L 19.36L 36.57L 25Cr 37.13L 97.57L 12Cr 97.89L 95.74L 42Cr |
Employees
8
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/26/31 | SEK 18.26 | +2.47% | 1,45,816 |
| 30/26/30 | SEK 17.82 | +2.41% | 1,54,259 |
| 29/26/29 | SEK 17.40 | +1.40% | 1,95,104 |
| 28/26/28 | SEK 17.16 | -6.02% | 2,87,766 |
| 27/26/27 | SEK 18.26 | -1.19% | 97,909 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SYNACT Stock
Select your edition
All financial news and data tailored to specific country editions
